Passionate about IP! Since June 2003 the IPKat has covered copyright, patent, trade mark, designs, info-tech and confidentiality issues from a mainly UK and European perspective. Read, post comments and participate!

The team is Eleonora Rosati, Annsley Merelle Ward and Merpel. E-mail the Kats here!

The team is joined by GuestKats Söğüt Atilla, Oliver Fairhurst, Claire Gregg, Georgia Jenkins and Marcel Pemsel.

SpecialKats: Verónica Rodríguez Arguijo (TechieKat), Rose Hughes (PatKat) and Jocelyn Bosse (Book Review Editor).

InternKats: Wissam Bentazar, Simone Lorenzi and Kliment Markov.
Results for IP and pharma
UCL IBIL Event: Boris v Corbyn v Trump - putting a price on patents, medicine and innovation UCL IBIL Event: Boris v Corbyn v Trump - putting a price on patents, medicine and innovation Reviewed by Annsley Merelle Ward on Friday, November 22, 2019 Rating: 5
Beyond exclusion of pharmaceutical products from patentable subject matter as a solution to limited access to medicines in Africa Beyond exclusion of pharmaceutical products from patentable subject matter as a solution to limited access to medicines in Africa Reviewed by Chijioke Okorie on Wednesday, July 31, 2019 Rating: 5
IP Pharma Challenges ... in Stockholm IP Pharma Challenges ... in Stockholm Reviewed by Eleonora Rosati on Thursday, May 30, 2019 Rating: 5
Subscribe to: Posts ( Atom )
Powered by Blogger.